Piramal Alternatives, the fund management division of the Piramal Group, on Monday said it has made a significant investment of Rs 110 crore in Noida-based Biodeal Pharmaceuticals, a contract development and manufacturing company, facilitated through convertible instruments from its Performing Credit Fund.